Abdominal #26

17-year-old male patient:
* Cholestatic jaundice, otherwise healthy
* Ultrasound showed extensive biliary tree dilatation

What should be done next?

What should be done next?

*MRCP
*Non-contrast MR of the abdomen with MRCP was performed

MRCP Images

MRCP Image

T2 images, axial and coronal

T2 Axial Image
T2 Coronal Image

DWI (left) with ADC map (right)

DWI with ADC map
Describe the findings

Describe the findings

*Marked biliary tree dilatation, common bile duct almost 2 cm wide with abrupt caliber change at the level of the pancreatic head
*No gallstones seen in biliary ducts or the distended gallbladder
*Diffuse pancreatic enlargement with marked restricted diffusion, no peripancreatic fat stranding, free fluid or collections
*Main pancreatic duct narrowing, barely visible

Differential diagnosis includes…

Differential diagnosis includes…

*Pancreatic cancer (especially diffuse infiltrative)
*Pancreatic lymphoma
*Autoimmune pancreatitis

Pancreatic biopsy confirmed autoimmune pancreatitis

Autoimmune pancreatitis is:
– Rare type of chronic pancreatitis
– Associated with IgG4-related sclerosing disease and autoimmune diseases
– Bulky appearance of the pancreas on imaging (“sausage shaped”), main pancreatic duct narrowing and absence of peripancreatic inflammatory changes seen in the acute pancreatitis
– Stenosis of the common bile duct is typical

What is the best course in treatment?

What is the best course in treatment?

Corticosteroids

Follow-up MRCP three weeks later showed improvement after corticosteroid therapy
Cholecystectomy was also performed

Pre-tearment
Follow-up after treatment

2 thoughts on “Abdominal #26

    1. Ultrasound images are unfortunately unavailable but are consistent with the MR findings.
      MRI with contrast would not add much value especially since no focal lesions are seen.
      ERCP is a good choice, but it is invasive and not necessary after MRCP. It would however be indicated if biliary stones were identified as a cause of obstruction.
      Percutaneous transhepatic cholangiography (PTC) is also invasive and more suited in therapeutic means for patients with malignant obstructions not amenable to stenting with ERCP.

Leave a Reply to EBR holderCancel reply